ScholarWorks@SUNGKYUNKWAN UNIVERSITY

Current filters:
Current filters:
Add filters:

Results 341-348 of 348 (Search time: 0.294 seconds).

SCIESCOPUS
Lazertinib as a frontline treatment in patients with EGFR-mutated advanced non-small cell lung cancer: Long-term follow-up results from LASER201open access

Chul Cho, Byoung; Han, Ji-Youn; Hyeong Lee, Ki; Lee, Yun-Gyoo; Kim, Dong-Wan; Joo Min, Young; Kim, Sang-We; Kyung Cho, Eun; Kim, Joo-Hang; Lee, Gyeong-Won, et al.

ArticleIssue Date2024CitationLung Cancer, v.190PublisherElsevier Ireland Ltd
SCIESCOPUS
Tarlatamab for patients (pts) with previously treated small cell lung cancer (SCLC): Primary analysis of the phase II DeLLphi-301 studyopen access

Paz-Ares, L.; Ahn, M-J.; Felip, E.; Handzhiev, S.; Korantzis, I.; Izumi, H.; Ohashi, K.; Majem, M.; Wolf, J.; Reck, M., et al.

ArticleIssue Date2023CitationANNALS OF ONCOLOGY, v.34, pp S1333 - S1334PublisherELSEVIER
SCIESCOPUS
A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17)

Kang, E. J.; Yang, Y.; Lee, S.; Kim, Y. J.; Lim, S. M.; Ahn, M-J.; Choi, Y. J.; Lee, Y.; Kim, T. M.; Kim, I., et al.

ArticleIssue Date2023CitationANNALS OF ONCOLOGY, v.34, pp S1178 - S1179PublisherELSEVIER
SCIESCOPUS
STAR-121: A Phase III Randomized Study of Domvanalimab and Zimberelimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Untreated Metastatic Non–Small Cell Lung Cancer With No Actionable Gene Alterations

Rodriguez-Abreu, Delvys; Bosch-Barrera, Joaquim; Gray, Jhanelle E.; Ahn, Myung-Ju; Johnson, Melissa; Yu, Xinwei; Mohammad, Saad; Chen, Xueying; Todd, Trever; Kim, Jongseok, et al.

ArticleIssue Date2024CitationClinical Lung Cancer, v.25, no.3, pp 274 - 279PublisherElsevier Inc.
SCIESCOPUS
Survival benefit in EGFR-wild and ALK negative NSCLC patients who participate in clinical trials compared to standard-of-care: Propensity-matched analysis

Jung, Hyun Ae; Park, Boram; Park, Sehhoon; Sun, Jong-Mu; Lee, Se-Hoon; Ahn, Jin Seok; Ahn, Myung-Ju

ArticleIssue Date2024CitationLung Cancer, v.190PublisherElsevier Ireland Ltd
SCIESCOPUS
Comprehensive analysis of transcription factor-based molecular subtypes and their correlation to clinical outcomes in small-cell lung canceropen access

Park, Sehhoon; Hong, Tae Hee; Hwang, Soohyun; Heeke, Simon; Gay, Carl M.; Kim, Jiyeon; Jung, Hyun-Ae; Sun, Jong-Mu; Ahn, Jin Seok; Ahn, Myung-Ju, et al.

ArticleIssue Date2024CitationeBioMedicine, v.102PublisherElsevier B.V.
SCIESCOPUS
Durvalumab in combination with chemoradiotherapy for patients with unresectable stage III non-small-cell lung cancer: Results from the phase 1 CLOVER studyopen access

Kim, Dong-Wan; Chul Cho, Byoung; Pachipala, Krishna; Kim, Sang-We; Wang, Chih-Liang; Chang, Gee-Chen; Ahn, Myung-Ju; Alvarez, Rosa; Chiu, Chao-Hua; Trigo, José, et al.

ArticleIssue Date2024CitationLung Cancer, v.190PublisherElsevier Ireland Ltd
SCIESCOPUS
Efficacy and safety of tepotinib in Asian patients with advanced NSCLC with <i>MET</i> exon 14 skipping enrolled in VISIONopen access

Kato, Terufumi; Yang, James Chih-Hsin; Ahn, Myung-Ju; Sakai, Hiroshi; Morise, Masahiro; Chen, Yuh-Min; Han, Ji-Youn; Yang, Jin-Ji; Zhao, Jun; Hsia, Te-Chun, et al.

ArticleIssue Date2024CitationBRITISH JOURNAL OF CANCER, v.130, no.10, pp 1679 - 1686PublisherSPRINGERNATURE
1 32 33 34 35

Discover

Date Issued

Type

Language

Journal Index

STATISTICS
Total View :5,386,887
Today View :0

RSS_1.0 RSS_2.0 ATOM_1.0

CONTACT US

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREAsamsunglib@skku.edu

COPYRIGHT © 2021 SUNGKYUNKWAN UNIVERSITY ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어